Cargando…
Understanding clinician perspectives on antibiotic associated adverse events to inform feedback
Background: Feedback regarding antibiotic-associated adverse events (ABX-AEs) may assist clinicians with antibiotic decision making. We sought to understand how clinicians account for ABX-AEs when prescribing and their preferences for ABX-AE feedback. Methods: We conducted 1-hour virtual focus group...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594371/ http://dx.doi.org/10.1017/ash.2023.265 |
_version_ | 1785124635101102080 |
---|---|
author | Cherian, Jerald Jones, George Helsel, Taylor Virk, Zunaira Salinas, Alejandra Grieb, Suzanne Keller, Sara Tamma, Pranita Cosgrove, Sara |
author_facet | Cherian, Jerald Jones, George Helsel, Taylor Virk, Zunaira Salinas, Alejandra Grieb, Suzanne Keller, Sara Tamma, Pranita Cosgrove, Sara |
author_sort | Cherian, Jerald |
collection | PubMed |
description | Background: Feedback regarding antibiotic-associated adverse events (ABX-AEs) may assist clinicians with antibiotic decision making. We sought to understand how clinicians account for ABX-AEs when prescribing and their preferences for ABX-AE feedback. Methods: We conducted 1-hour virtual focus groups with 3–5 physicians or advance practice practitioners (APPs) per session at Johns Hopkins Hospital. Participants discussed the role of ABX-AEs in antibiotic decision making and feedback preferences. Participants evaluated prespecified categorization (mildly, moderately, or very concerning) of several ABX-AEs. Focus groups were recorded and transcribed. Transcripts were coded inductively by 2 independent reviewers; discrepancies were resolved by consensus. Codes were used to conduct thematic analysis. Results: Overall, 3 focus groups were conducted with 12 participants: 41.6% were house staff, 16.7% were attending physicians, and 41.6% were APPs. Most were female (91.6%) and were white (41.7%) or Asian (41.7%). Clinicians generally agreed with the prespecified categorizations of ABX-AEs based on degree of clinical concern (Table). We identified 5 themes: (1) The risk of ABX-AE is considered during initial prescribing but influences agent selection more than the decision to prescribe antibiotics. (2) The occurrence of an ABX-AE leads to assessment of need for continued antibiotic therapy. (3) The impact of an ABX-AE on other management decisions is as important as the direct harm of the ABX-AE when assessing severity. (4) Feedback must be curated to prevent clinicians from being overwhelmed with data. (5) Clinicians will be more receptive to feedback regarding ABX-AEs if feedback is contextualized (Fig.). Conclusions: The themes identified and assessment of ABX-AEs of greatest clinical concern may help inform the development of effective ABX-AE feedback methods to improve antibiotic safety. Disclosures: None |
format | Online Article Text |
id | pubmed-10594371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105943712023-10-25 Understanding clinician perspectives on antibiotic associated adverse events to inform feedback Cherian, Jerald Jones, George Helsel, Taylor Virk, Zunaira Salinas, Alejandra Grieb, Suzanne Keller, Sara Tamma, Pranita Cosgrove, Sara Antimicrob Steward Healthc Epidemiol Antibiotic Stewardship Background: Feedback regarding antibiotic-associated adverse events (ABX-AEs) may assist clinicians with antibiotic decision making. We sought to understand how clinicians account for ABX-AEs when prescribing and their preferences for ABX-AE feedback. Methods: We conducted 1-hour virtual focus groups with 3–5 physicians or advance practice practitioners (APPs) per session at Johns Hopkins Hospital. Participants discussed the role of ABX-AEs in antibiotic decision making and feedback preferences. Participants evaluated prespecified categorization (mildly, moderately, or very concerning) of several ABX-AEs. Focus groups were recorded and transcribed. Transcripts were coded inductively by 2 independent reviewers; discrepancies were resolved by consensus. Codes were used to conduct thematic analysis. Results: Overall, 3 focus groups were conducted with 12 participants: 41.6% were house staff, 16.7% were attending physicians, and 41.6% were APPs. Most were female (91.6%) and were white (41.7%) or Asian (41.7%). Clinicians generally agreed with the prespecified categorizations of ABX-AEs based on degree of clinical concern (Table). We identified 5 themes: (1) The risk of ABX-AE is considered during initial prescribing but influences agent selection more than the decision to prescribe antibiotics. (2) The occurrence of an ABX-AE leads to assessment of need for continued antibiotic therapy. (3) The impact of an ABX-AE on other management decisions is as important as the direct harm of the ABX-AE when assessing severity. (4) Feedback must be curated to prevent clinicians from being overwhelmed with data. (5) Clinicians will be more receptive to feedback regarding ABX-AEs if feedback is contextualized (Fig.). Conclusions: The themes identified and assessment of ABX-AEs of greatest clinical concern may help inform the development of effective ABX-AE feedback methods to improve antibiotic safety. Disclosures: None Cambridge University Press 2023-09-29 /pmc/articles/PMC10594371/ http://dx.doi.org/10.1017/ash.2023.265 Text en © The Society for Healthcare Epidemiology of America 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Antibiotic Stewardship Cherian, Jerald Jones, George Helsel, Taylor Virk, Zunaira Salinas, Alejandra Grieb, Suzanne Keller, Sara Tamma, Pranita Cosgrove, Sara Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
title | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
title_full | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
title_fullStr | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
title_full_unstemmed | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
title_short | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
title_sort | understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
topic | Antibiotic Stewardship |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594371/ http://dx.doi.org/10.1017/ash.2023.265 |
work_keys_str_mv | AT cherianjerald understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT jonesgeorge understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT helseltaylor understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT virkzunaira understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT salinasalejandra understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT griebsuzanne understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT kellersara understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT tammapranita understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT cosgrovesara understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback |